AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11134261
Drug: Profiled treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Profiled treatments
Trial: 9617983
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate (300 mg every 12 hours) with naproxen sodium
Trial: 15704481
Drug: Phezam treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phezam treatment for 2 months in routine practice
Trial: 26210120
Drug: Topical fluoride
RxNorm normalized name: Carles 60 Second APF 1.23% Topical Fluoride Dental Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical fluoride applications (IPFA)
Trial: 2014931
Drug: Bambuterol 5
RxNorm normalized name: bambuterol
DrugBank: Bambuterol (DB01408)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol 5 mg
Trial: 16897026
Drug: Active integration
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active integration in treatment decisions
Trial: 2037541
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B (200 mg four times daily)
Trial: 1849810
Drug: Serotonin highest
RxNorm normalized name: serotonin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin highest dose
Trial: 28067718
Drug: CYD-TDV administered
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYD-TDV administered as a 3-dose schedule
Trial: 26232126
Drug: Probiotic milk
RxNorm normalized name: PROBIOTIC
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic milk containing Lactobacillus rhamnosos GG, L. acidophilus La‐5, and Bifidobacterium animalis subsp. lactis Bb‐12
Trial: 20643863
Drug: Single-agent PLD
RxNorm normalized name: pLDLR-Neo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent PLD
Trial: 25801797
Drug: Velaglucerase alfa
RxNorm normalized name: Velaglucerase alfa
DrugBank: Velaglucerase alfa (DB06720)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Velaglucerase alfa intravenous infusions at 60 U/kg every other week for 1.2-4.8 years
Trial: 25801797
Drug: Velaglucerase alfa
RxNorm normalized name: Velaglucerase alfa
DrugBank: Velaglucerase alfa (DB06720)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Velaglucerase alfa intravenous infusions
Trial: 14663474
Drug: Finasteride 5
RxNorm normalized name: finasteride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 5 mg once daily
Trial: 25056655
Drug: Yogurt containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yogurt containing polydextrose, L. acidophilus NCFM, and B. lactis HN019 (Treatment Group)
Trial: 19181414
Drug: Behavioural medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural medicine intervention
Trial: 17065180
Drug: Trimetazidine (TMZ)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (TMZ) and isotonic saline infusion
Trial: 23754631
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g Spirulina (Arthrospira platensis) per day for 12 weeks
Trial: 16202854
Drug: Enalapril (E)
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril (E) 10 mg
Trial: 17907081
Drug: Cytostatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytostatic therapy
Trial: 26746199
Drug: General response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: General response to fluoride treatments
Trial: 24141646
Drug: Paracetamol 1
RxNorm normalized name: Paracetamol 1 g oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 1 g
Trial: 25223711
Drug: Fresh pomegranate
RxNorm normalized name: Pomegranate
DrugBank: Pomegranate (DB14317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh pomegranate juice (PJ), 1.5 mL per kg body weight
Trial: 30881102
Drug: Oliceridine 0.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oliceridine 0.35 mg
Trial: 28341415
Drug: Standard diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard diuretic strategy
Trial: 9735662
Drug: Specific IgE
RxNorm normalized name: BSA specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific IgE (slgE) antibodies
Trial: 9735662
Drug: Specific IgG4
RxNorm normalized name: PACIFIC OYSTER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific IgG4 (slgG4) antibodies
Trial: 396656
Drug: Pirenzepine (PRZ)
RxNorm normalized name: pirenzepine
DrugBank: Pirenzepine (DB00670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (PRZ) 150 mg daily
Trial: 30294552
Drug: Insulin pump
RxNorm normalized name: insulin pump syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin pump therapy
Trial: 2137901
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g per day of corn oil
Trial: 16963663
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (IV administration)
Trial: 20966402
Drug: Moderate or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate or intensive statin therapy
Trial: 9669459
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no saliva stimulants)
Trial: 28533290
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate 800 mg/day
Trial: 11097665
Drug: Epidural injection
RxNorm normalized name: Sufentanil Citrate 50 ug in 1 mL EPIDURAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injection of 10 mL saline
Trial: 30517252
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of magnesium sulfate during the induction of anesthesia
Trial: 26423618
Drug: 3.6 mg
RxNorm normalized name: menthol 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.6 mg pegteograstim
Trial: 22674719
Drug: sulfaphenazole +
RxNorm normalized name: Sulfathiazole
DrugBank: Sulfathiazole (DB06147)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sulfaphenazole + l‐NAME
Trial: 31980978
Drug: Dotinurad 2
RxNorm normalized name: Dotinurad
DrugBank: Dotinurad (DB16145)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Dotinurad 2 mg
Trial: 30371826
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Treatment + Contingency Management (CBT + CM)
Trial: 18385595
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Morphine PCA without Naloxone)
Trial: 1483879
Drug: 4 mL
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mL hyperbaric tetracaine
Trial: 21876297
Drug: Ultrasound (US)
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound (US) treatment with continuous wave of 1.5w/cm² for 10 minutes before stretching
Trial: 3470899
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of hexetidine and zinc ions
Trial: 394563
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of estradiol (10 mg) and testosterone (200 mg) esters administered immediately after delivery
Trial: 21851299
Drug: Infected with
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infected with 1.5 x 10^9 cfu M. haemolytica in 5 mL sterile nutrient broth
Trial: 16704735
Drug: Artemether-lumefantrine (AL)
RxNorm normalized name: ARTEMETHER/LUMEFANTRINE
DrugBank: Lumefantrine co-artemether (DB13085)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemether-lumefantrine (AL) - 6-dose course (20/120 mg tablets) over three days
Trial: 3135144
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg oral lithium carbonate load (8.1 mmol of elemental lithium)
Trial: 17049927
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with counseling as usual (TAU)
Trial: 9549636
Drug: Riluzole 75
RxNorm normalized name: Riluzole
DrugBank: Riluzole (DB00740)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Riluzole 75 mg twice daily
Trial: 9549636
Drug: Multiple-dose administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple-dose administration of riluzole
Trial: 23620938
Drug: Fire needle
RxNorm normalized name: Fire Out
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fire needle combined with narrow band ultraviolet-B (NB-UVB) therapy
Trial: 23620938
Drug: Narrow band
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrow band ultraviolet-B (NB-UVB) therapy
Trial: 31608930
Drug: Ghrelin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ghrelin infusion
Trial: 20393175
Drug: Azathioprine monotherapy
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine monotherapy
Trial: 19258524
Drug: Ibuprofen (IBU)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (IBU) 12.5 mg/kg
Trial: 29663320
Drug: Direct-to-implant breast
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct-to-implant breast reconstruction with acellular dermal matrix (ADM)
Trial: 30232048
Drug: GFF MDI
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GFF MDI (glycopyrrolate/formoterol fumarate metered‐dose inhaler 18/9·6 μg)
Trial: 25487708
Drug: SIRT +
RxNorm normalized name: Sirturo
DrugBank: Bedaquiline (DB08903)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: SIRT + mFOLFOX6 (with a reduced dose of oxaliplatin in cycles 1-3 following SIRT)
Trial: 8546909
Drug: Granisetron 40
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron 40 micrograms kg‐1 intravenously (i.v.) on day 1, dexamethasone 20 mg i.v. on days 2 and 3 and prochlorperazine 5 mg orally thrice daily on days 1‐5
Trial: 1180955
Drug: Oral prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prostaglandin E2 tablets 0.5 mg hourly
Trial: 18403419
Drug: Flexible GnRH
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flexible GnRH antagonist protocol
Trial: 16476256
Drug: PUVA baths
RxNorm normalized name: colloidal oatmeal
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUVA baths (photosensitizer 8‐methoxypsoralen at a concentration of 2.6 mg/l)
Trial: 18192785
Drug: Acyclovir 400
RxNorm normalized name: acyclovir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 400 mg twice daily
Trial: 16909787
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for neuroborreliosis
Trial: 31248950
Drug: Esaxerenone 5
RxNorm normalized name: Esaxerenone
DrugBank: Esaxerenone (DB15207)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Esaxerenone 5 mg/d
Trial: 15131541
Drug: tenectaplase monotherapy
RxNorm normalized name: Tenecteplase
DrugBank: Tenecteplase (DB00031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: tenectaplase monotherapy
Trial: 17875198
Drug: Doubling the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doubling the proton pump inhibitor dose
Trial: 6215443
Drug: Both drug
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both drug groups
Trial: 15821526
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride 20 mg tablets
Trial: 12819976
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no photodynamic therapy)
Trial: 29420600
Drug: Ambient precipitation
RxNorm normalized name: Precipitated Sulfur
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambient precipitation treatment
Trial: 1833105
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil extract (total EPA dose of 2.4 g/day) for 6 weeks
Trial: 17531002
Drug: Bivalent gp120
RxNorm normalized name: L1 protein, human papillomavirus type 16 vaccine
DrugBank: Human papillomavirus type 16 L1 capsid protein antigen (DB10301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent gp120 vaccine
Trial: 10811335
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran 20 g/day
Trial: 506799
Drug: Glucocorticoid administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucocorticoid administration for 24 hours during phenformin treatment
Trial: 27615436
Drug: Naftopidil 75
RxNorm normalized name: Naftopidil
DrugBank: Naftopidil (DB12092)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Naftopidil 75 mg per day
Trial: 2096482
Drug: Thymus gland
RxNorm normalized name: thymus gland
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymus gland preparations (Thymu‐Skin)
Trial: 2557268
Drug: Beta-blocker atenolol
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Beta-blocker atenolol
Trial: 8993958
Drug: Cetirizine 20
RxNorm normalized name: cetirizine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 20 mg/day
Trial: 1287614
Drug: Cefaclor AF
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor AF 750 mg twice daily
Trial: 2992839
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (2 mg and 4 mg)
Trial: 17070426
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II receptor antagonist therapy in echo group
Trial: 11420773
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg estradiol‐17 beta with cyclical dydrogesterone
Trial: 3936081
Drug: Citalopram 5
RxNorm normalized name: escitalopram 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 5 mg
Trial: 23261048
Drug: 5-valent oral
RxNorm normalized name: L1 protein, human papillomavirus type 31 vaccine
DrugBank: Human papillomavirus type 31 L1 capsid protein antigen (DB10310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-valent oral rotavirus vaccine (3 doses)
Trial: 21437317
Drug: Active after-sun
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active after-sun (AS) lotion containing DNA-repair enzymes (photolyase from Anacystis nidulans and Micrococcus luteus extract with endonuclease activity)
Trial: 29319935
Drug: Tablet A
RxNorm normalized name: tablet administration aid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet A (50 mg)
Trial: 29319935
Drug: Tablet B
RxNorm normalized name: Biaxin 4 Tablet Blister Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet B (50 mg)
Trial: 1857725
Drug: Low-Calcium diet
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Calcium diet (163 +/- 1 mg/day)
Trial: 23375965
Drug: 0.2 g
RxNorm normalized name: methionine 0.2 gram ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 g intravenous immunoglobulin per kg every 4 weeks
Trial: 25411597
Drug: Ipragliflozin 100
RxNorm normalized name: BEXAGLIFLOZIN
DrugBank: Bexagliflozin (DB12236)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipragliflozin 100 mg
Trial: 11320385
Drug: Vi-rEPA vaccine
RxNorm normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vi-rEPA vaccine (1 injection)
Trial: 11320385
Drug: Vi-rEPA vaccine
RxNorm normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vi-rEPA vaccine
Trial: 7298477
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment
Trial: 8835624
Drug: Intravenous atropine
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous atropine (0.03 mg/kg i.v.)
Trial: 19643983
Drug: Subcutaneous alemtuzumab
RxNorm normalized name: Alemtuzumab
DrugBank: Alemtuzumab (DB00087)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Subcutaneous alemtuzumab
Trial: 21615691
Drug: Ketorolac 20
RxNorm normalized name: ketorolac 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 20 mg
Trial: 31522153
Drug: Combined orthodontic
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined orthodontic regenerative therapy with laser irradiation (Group I: test group)
Trial: 10094221
Drug: Suplatast tosilate
RxNorm normalized name: Edoxaban Tosylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suplatast tosilate and bufexamac ointment
Trial: 30998747
Drug: 81mg of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 81mg of aspirin + 400mcg of folic acid
Trial: 8556568
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray (FPANS)
Trial: 15121266
Drug: Low-dose midazolam
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose midazolam with propofol (0.03 mg/kg midazolam + 0.7 mg/kg bolus propofol + 2 mg/kg/h propofol infusion)
Trial: 15121266
Drug: Propofol alone
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol alone (0.7 mg/kg bolus propofol + 2 mg/kg/h propofol infusion)
Trial: 9639218
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg intravenous dexamethasone over 36 hours
Trial: 12508476
Drug: Levofloxacin 100
RxNorm normalized name: levofloxacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 100 mg 3 times daily
Trial: 25841133
Drug: 2500 IU
RxNorm normalized name: Vitamin A/Vitamin D 2500 IU-270 IU Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2500 IU heparin
Trial: 9663365
Drug: Acarbose 100
RxNorm normalized name: acarbose 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose 100 mg plus Beano
Trial: 23440660
Drug: Cynara scolymus
RxNorm normalized name: Cynara scolymus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cynara scolymus extract (600 mg/d)
Trial: 2262233
Drug: Topical indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical indomethacin
Trial: 19507410
Drug: Povidone-iodine solution
RxNorm normalized name: POVIDONE-IODINE 1 g in 100 mL TOPICAL LIQUID [Loris Povidone-Iodine Solution]
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone-iodine solution
Trial: 22127270
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg EGCG
Trial: 19409341
Drug: Headgear (HG)
RxNorm normalized name: guaifenesin / hydrocodone bitartrate Oral Solution [Hydro-Tussin HG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Headgear (HG) treatment started immediately with no other appliances used during the first 2 years
Trial: 11695354
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg once daily
Trial: 3109574
Drug: Intravenous sodium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sodium heparin
Trial: 9170398
Drug: Short-acting nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-acting nifedipine 30 mg/d